In summary, this study is the first, to the best of our knowledge, to unveil that NSCLC cells can elevate FLOT1 expression to launch a defense against radiotherapy through stimulating cell migration, impeding radiation-induced DNA damage, and inducing tumor immune desertification. The gene discussed is FLOT1; the disease is non-small cell lung carcinoma.